Journal of Parkinson's Disease - Volume 10, issue s1

Authors: Bloem, Bastiaan R. | Brundin, Patrik

Article Type: Editorial

Keywords: Parkinson’s disease, clinical care, management, treatment, multidisciplinary, non-pharmacological interventions

DOI: 10.3233/JPD-209003

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S1-S3, 2020

Authors: Andrejack, John | Mathur, Soania

Article Type: Review Article

Abstract: Parkinson’s disease is an incurable, progressive neurodegenerative disease. This condition is complicated by the varying symptoms in individuals who differ in age of onset, symptoms, progression of disease, response to treatment and prognosis. In this paper, we focus on quality of life achieved through a combination of comprehensive health care, continuous support, and self care. Determining what people with Parkinson’s disease want is like assembling multiple puzzles simultaneously. While we surmise that patient centered care, support programs, access to comprehensive health care, and relevant symptom control are pieces of this puzzle, more longitudinal studies— which are observational in nature and …correlate the impact of symptoms with patients’ reported needs— are necessary. Show more

Keywords: Patient-centered care, quality of life, self-care, fatigue, sleep wake disorders, movement disorders

DOI: 10.3233/JPD-202107

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S5-S10, 2020

Authors: van Halteren, Angelika D. | Munneke, Marten | Smit, Eva | Thomas, Sue | Bloem, Bastiaan R. | Darweesh, Sirwan K. L.

Article Type: Review Article

Abstract: There is a growing awareness that delivery of integrated and personalized care is necessary to meet the needs of persons living with Parkinson’s disease. In other chronic diseases than Parkinson’s disease, care management models have been deployed to deliver integrated and personalized care, yielding positive effects on patients’ health outcomes, quality of life and health care utilization. However, care management models have been highly heterogeneous, as there is currently no clear operationalization of its core elements. In addition, most care management models are disease-specific and not tailored to the individual needs and preferences of a patient. In this viewpoint we …present an integrated and personalized care management model for persons with Parkinson’s disease costing of five core elements: (1) care coordination, (2) patient navigation, (3) information provision, (4) early detection of signs and symptoms through proactive monitoring and (5) process monitoring. Following the description of each core element, implications for implementing the model into practice are discussed. Finally, we provide clinical and methodological considerations on the evaluation of care management models. Show more

Keywords: Parkinson’s disease, disease management, delivery of integrated healthcare, patient care team, patient navigation

DOI: 10.3233/JPD-202126

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S11-S20, 2020

Authors: Alberts, Jay L. | Rosenfeldt, Anson B.

Article Type: Review Article

Abstract: Over the past two decades, aerobic exercise has emerged as a mainstream recommendation to aid in treating Parkinson’s disease (PD). Despite the acknowledgement of the benefits of exercise for people with PD (PwPD), frequently, exercise recommendations lack specificity in terms of frequency, intensity and duration. Additionally, conflating physical activity with exercise has contributed to providing vague exercise recommendations to PwPD. Therefore, the beneficial effects of exercise may not be fully realized in PwPD. Data provided by animal studies and select human trials indicate aerobic exercise may facilitate structural and functional changes in the brain. Recently, several large human clinical trials …have been completed and collectively support the use of aerobic exercise, specifically high-intensity aerobic exercise, in improving PD motor symptoms. Data from these and other studies provide the basis to include aerobic exercise as an integral component in treating PD. Based on positive clinical findings and trials, it is advised that PwPD perform aerobic exercise in the following dose: 3x/week, 30–40-minute main exercise set, 60–80% of heart rate reserve or 70–85% of heart rate max. In lieu of heart rate, individuals can achieve an intensity of 14–17 on a 20-point RPE scale. Ongoing clinical trials, SPARX3 and CYCLE-II, have potential to further develop patient-specific exercise recommendations through prognostic modeling. Show more

Keywords: Parkinson’s disease, exercise, aerobic exercise, physical activity

DOI: 10.3233/JPD-202100

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S21-S27, 2020

Authors: Post, Bart | van den Heuvel, Lieneke | van Prooije, Teije | van Ruissen, Xander | van de Warrenburg, Bart | Nonnekes, Jorik

Article Type: Review Article

Abstract: In people with young onset Parkinson’s disease (YOPD), onset of symptoms is between 21 and 40 years of age. The distinction between YOPD and late-onset Parkinson’s disease is supported by genetic differences (a genetic etiology is more common in people with YOPD) and clinical differences (e.g., dystonia and levodopa-induced dyskinesias are more common inYOPD). Moreover, people with YOPD tend to have different family and societal engagements compared to those with late-onset PD. These unique features have implications for clinical management, and call for a tailored multidisplinary approach involving shared-decision making.

Keywords: Parkinsons’s disease, young-onset, quality of life, work, caregiver, genetics, dystonia

DOI: 10.3233/JPD-202135

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S29-S36, 2020

Authors: Buhmann, Carsten | Kassubek, Jan | Jost, Wolfgang H.

Article Type: Review Article

Abstract: Pain is a very frequent symptom with influence on the quality of life in Parkinson’s disease (PD), but is still underdiagnosed and commonly treated only unsystematically. Pain etiology and pain character are often complex and multi-causal, and data regarding treatment recommendations are limited. Pain can be primarily related to PD but frequently it is associated with secondary diseases, such as arthrosis of the spine or joints. However, even basically PD-unrelated pain often is amplified by motor- or non-motor PD symptoms, such as akinesia or depression. Beyond an optimization of anti-parkinsonian treatment, additional pain treatment strategies are usually needed to properly …address pain in PD. A careful pain history and diagnostic work-up is essential to rate the underlying pain pathophysiology and to develop a targeted therapeutic concept. This review gives an overview on how pain is treated in PD patients and how patients assess the effectiveness of these therapies; here, the manuscript focuses on pathophysiology-driven suggestions for a multimodal pain management in clinical practice. Show more

Keywords: Parkinson’s disease, pain, therapy, analgetics, pathophysiology, non-motor symptoms

DOI: 10.3233/JPD-202069

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S37-S48, 2020

Authors: Savitt, Joseph | Aouchiche, Rachid

Article Type: Review Article

Abstract: Parkinson’s disease (PD) is a movement disorder with many symptoms responsive to treatment with dopamine agonists, anti-cholinergics and the dopamine precursor, levodopa. The cardinal features of PD include tremor, rigidity, bradykinesia, and postural instability. There also are non-motor features that include sleep disorders, cognitive and affective dysfunction, hyposmia, pain and dysautonomia (constipation, bloating, orthostasis, urinary symptoms, sexual dysfunction, dysphagia). Among these non-motor features are signs and symptoms of visual system impairment that range from subtle examination findings to those causing severe disability. In this review we describe common PD-related abnormalities in the visual system, how they present, and potential treatments.

Keywords: Parkinson’s disease, vision, hallucination, diplopia, dry eye

DOI: 10.3233/JPD-202103

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S49-S56, 2020

Authors: Fanciulli, Alessandra | Leys, Fabian | Falup-Pecurariu, Cristian | Thijs, Roland | Wenning, Gregor K.

Article Type: Review Article

Abstract: Orthostatic hypotension (OH) is a common non-motor feature of Parkinson’s disease that may cause unexplained falls, syncope, lightheadedness, cognitive impairment, dyspnea, fatigue, blurred vision, shoulder, neck, or low-back pain upon standing. Blood pressure (BP) measurements supine and after 3 minutes upon standing screen for OH at bedside. The medical history and cardiovascular autonomic function tests ultimately distinguish neurogenic OH, which is due to impaired sympathetic nerve activity, from non-neurogenic causes of OH, such as hypovolemia and BP lowering drugs. The correction of non-neurogenic causes and exacerbating factors, lifestyle changes and non-pharmacological measures are the cornerstone of OH treatment. If these …measures fail, pharmacological interventions (sympathomimetic agents and/or fludrocortisone) should be introduced stepwise depending on the severity of symptoms. About 50% of patients with neurogenic OH also suffer from supine and nocturnal hypertension, which should be monitored for with in-office, home and 24 h-ambulatory BP measurements. Behavioral measures help prevent supine hypertension, which is eventually treated with non-pharmacological measures and bedtime administration of short-acting anti-hypertensive drugs in severe cases. If left untreated, OH impacts on activity of daily living and increases the risk of syncope and falls. Supine hypertension is asymptomatic, but often limits an effective treatment of OH, increases the risk of hypertensive emergencies and, combined with OH, facilitates end-organ damage. A timely management of both OH and supine hypertension ameliorates quality of life and prevents short and long-term complications in patients with Parkinson’s disease. Show more

Keywords: Parkinson’s disease, orthostatic hypotension, post-prandial hypotension, supine hypertension, nocturnal hypertension

DOI: 10.3233/JPD-202036

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S57-S64, 2020

Authors: Dijk, Joke M. | Espay, Alberto J. | Katzenschlager, Regina | de Bie, Rob M.A.

Article Type: Review Article

Abstract: When oral dopaminergic medication falls short in the treatment of Parkinson’s disease, patients are left with motor response fluctuations and dyskinesias that may have a large impact on functioning in daily life. They may benefit from one of the currently available advanced treatments, namely deep brain stimulation, continuous levodopa-carbidopa intestinal gel, and continuous subcutaneous apomorphine infusion. The indication, choice between the separate advanced treatments and the timing can be challenging and will be discussed against the background of the progressive nature of the disease, the heterogeneity of disease manifestation and variable patient characteristics.

Keywords: Parkinson’s disease, deep brain stimulation, external infusion pumps, parenteral infusions, carbidopa, levodopa drug combination, apomorphine, review literature

DOI: 10.3233/JPD-202104

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S65-S73, 2020

Authors: Fabbri, Margherita | Kauppila, Linda Azevedo | Ferreira, Joaquim J | Rascol, Olivier

Article Type: Review Article

Abstract: Parkinson’s disease (PD) is a common neurodegenerative disorder, with a continuously increasing prevalence. With improved clinical and therapeutic management of PD, more patients reach later stages of the disease, meaning they may face new clinical problems that were not commonly approached. This gave way to the description of a new PD stage, late-stage PD (LSPD), which is clinically discernible from the advanced-stage one. Therefore, LSPD patients have new and different needs, regarding pharmacological and non pharmacological interventions, including palliative care and multidisciplinary teams. LSPD patients constitute an‘orphan population’, who traditionally was excluded from previous studies, due to its high disability. …With this manuscript, we intend to review specific management challenges of LSPD patients, covering this new concept and its clinical features, how to assess these patients, therapeutic recommendations, as well as discussing ongoing research and future perspectives. Show more

Keywords: Parkinson’s disease, late-stage, palliative care, multidisciplinary care, caregivers

DOI: 10.3233/JPD-202096

Citation: Journal of Parkinson's Disease, vol. 10, no. s1, pp. S75-S83, 2020